(Q41543502)

2 October 2017

1 reference

title

Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli (English)

1 reference

2 October 2017

Gram-negative bacteria

0 references

author name string

Pitout JD

series ordinal

1

1 reference

2 October 2017

Sanders CC

series ordinal

2

1 reference

2 October 2017

Sanders WE Jr

series ordinal

3

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

American Journal of Medicine

2 October 2017

1 reference

2 October 2017

103

1 reference

2 October 2017

1

1 reference

2 October 2017

51-59

1 reference

Penicillin-binding proteins and bacterial resistance to beta-lactams

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Resistance to antibiotics mediated by target alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Outer membrane barrier as a mechanism of antimicrobial resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

beta-Lactamases of gram-negative bacteria: new challenges for new drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

A functional classification scheme for beta-lactamases and its correlation with molecular structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Beta-lactam susceptibility of Haemophilus influenzae strains showing reduced susceptibility to cefuroxime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Predominant pathogens in hospital infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Mechanisms of resistance to the carbapenems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Prevention of drug access to bacterial targets: permeability barriers and active efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

Health and economic impacts of antimicrobial resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900044-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(97)00044-2

1 reference

2 October 2017

1 reference